Idiopathic autoimmune hemolytic anemia (AIHA) is an acquired disease that occurs when antibodies form against a person's own red blood cells. One of the most important issues associated with the early diagnosis and acute management of AIHA is the communication between the blood banker and the hematologist. Diagnosis followed by acute and chronic management of AIHA involves the use of appropriate diagnostics to suspect, confirm, and manage the treatment of patients with AIHA. This webinar reviewed these tenets to ensure that patients with AIHA receive the highest quality of care. ASH is grateful to The Henry Loring Masters Foundation for building awareness among caregivers, patients, and families of the critical path and timelines for treatment of Autoimmune Hemolytic Anemia (AIHA) in young people and for providing support for the development and distribution of this valuable webinar.
Presentation and Speakers
Clinical Presentation Associated with Autoimmune Hemolytic Anemia
Speaker: Marc Kahn, MD, MBA, Tulane University School of Medicine, New Orleans, LA
Dr. Kahn discussed symptoms associated with AIHA, the differential diagnosis in this group of patients and the laboratory tests used to confirm diagnosis. Dr. Kahn also presented information regarding the acute and long term management of AIHA patients.
Role of the Blood Bank in Making the Diagnosis and Communication with the Hematologist
Speaker: Leslie E. Silberstein, MD, Boston Children’s Hospital, Boston, MA
Dr. Silberstein presented information related to the important role of the blood bank in making the diagnosis, how and when blood transfusions are an acceptable treatment for patients with AIHA, including challenges in finding the best matched blood cells for transfusion. He also discussed the important roles of the blood banker and hematologist in managing the quality of care for these patients.
Samuel M. Silver, MD, PhD, University of Michigan Medical School, Ann Arbor, MI